“…Two-tier testing was developed for surveillance purposes and should not be used alone outside of clinical judgment in diagnosing and treating Lyme disease (107). Similarly, it is neither sensitive nor specific in clinically evaluating persistent symptoms in the context of previous antibiotic treatment.…”